Back to Journals » Drug Design, Development and Therapy » Volume 9 » The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells
Please verify you are not a robot.